FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Zivin

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Physiology

Concepts & Ideas

Procedures

Anatomy

Tumor Cells, Cultured

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Paul Burnett; Janet K Robertson; Jeffrey M Palmer; Richard R Ryan; Adrienne E Dubin; Robert A Zivin
Fluorescence imaging of electrically stimulated cells.
Mitsuo Aono; Yoonki Lee; Elfrida R Grant; Robert A Zivin; Robert D Pearlstein; David S Warner; Ellen R Bennett; Daniel T Laskowitz
Apolipoprotein E protects against NMDA excitotoxicity.
Tammy O Utset; Julie A Auger; Donna Peace; Robert A Zivin; Danlin Xu; Linda Jolliffe; Maria-Luisa Alegre; Jeffrey A Bluestone; Marcus R Clark
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Zivin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Paul Burnett; Janet K Robertson; Jeffrey M Palmer; Richard R Ryan; Adrienne E Dubin; Robert A Zivin
Fluorescence imaging of electrically stimulated cells.
Journal of biomolecular screening 2003;8(6):660-7.
2002: Mitsuo Aono; Yoonki Lee; Elfrida R Grant; Robert A Zivin; Robert D Pearlstein; David S Warner; Ellen R Bennett; Daniel T Laskowitz
Apolipoprotein E protects against NMDA excitotoxicity.
Neurobiology of disease 2002;11(1):214-20.
2002: Tammy O Utset; Julie A Auger; Donna Peace; Robert A Zivin; Danlin Xu; Linda Jolliffe; Maria-Luisa Alegre; Jeffrey A Bluestone; Marcus R Clark
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
The Journal of rheumatology 2002;29(9):1907-13.
2002: Kevan C Herold; William Hagopian; Julie A Auger; Ena Poumian-Ruiz; Lesley Taylor; David Donaldson; Stephen E Gitelman; David M Harlan; Danlin Xu; Robert A Zivin; Jeffrey A Bluestone
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.
The New England journal of medicine 2002;346(22):1692-8.
2002: Elfrida R Grant; Adrienne E Dubin; Sui-Po Zhang; Robert A Zivin; Zhong Zhong
Simultaneous intracellular calcium and sodium flux imaging in human vanilloid receptor 1 (VR1)-transfected human embryonic kidney cells: a method to resolve ionic dependence of VR1-mediated cell death.
The Journal of pharmacology and experimental therapeutics 2002;300(1):9-17.
2001: Robin Thurmond; S A Wadsworth; PH Schafer; Robert A Zivin; John Siekierka
Kinetics of small molecule inhibitor binding to p38 kinase.
European journal of biochemistry / FEBS 2001;268(22):5747-54.
2001: Patricia Kraft; Donna Haynes-Johnson; L Patel; Judy A Lenhart; Robert A Zivin; Stephen S Palmer
Fluorescence polarization assay and SDS-PAGE confirms matrilysin degrades fibronectin and collagen IV whereas gelatinase A degrades collagen IV but not fibronectin.
Connective tissue research 2001;42(2):149-63.
2001: Michael Burczynski; Michael McMillian; J Brandon Parker; Stewart Bryant; Angelique Leone; Elfrida R Grant; J M Thorne; Zhong Zhong; Robert A Zivin; Mark D Johnson
Cytochrome P450 induction in rat hepatocytes assessed by quantitative real-time reverse-transcription polymerase chain reaction and the RNA invasive cleavage assay.
Drug metabolism and disposition: the biological fate of chemicals 2001;29(9):1243-50.
2001: Elfrida R Grant; M A Errico; S L Emanuel; Daniel Benjamin; Michael McMillian; S A Wadsworth; Robert A Zivin; Zhong Zhong
Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells.
Biochemical pharmacology 2001;62(3):283-96.
2001: Michael McMillian; Elfrida R Grant; Zhong Zhong; J Brandon Parker; L Li; Robert A Zivin; Michael Burczynski; Mark D Johnson
Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis.
In vitro & molecular toxicology 2001;14(3):177-90.
2000: Danlin Xu; M L Alegre; SS Varga; A L Rothermel; A M Collins; Virginia L Pulito; L S Hanna; K P Dolan; P W Parren; Jeffrey A Bluestone; Linda Jolliffe; Robert A Zivin
In vitro characterization of five humanized OKT3 effector function variant antibodies.
Cellular immunology 2000;200(1):16-26.
1999: E Steve Woodle; Danlin Xu; Robert A Zivin; Julie A Auger; J Charette; R O'Laughlin; Donna Peace; L K Jollife; T Haverty; Jeffrey A Bluestone; J Richard Thistlethwaite
Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
Transplantation 1999;68(5):608-16.
1999: J Richards; Julie A Auger; Donna Peace; D Gale; J Michel; A Koons; T Haverty; Robert A Zivin; Linda Jolliffe; Jeffrey A Bluestone
Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4.
Cancer research 1999;59(9):2096-101.
1998: E Steve Woodle; Jeffrey A Bluestone; Robert A Zivin; Linda Jolliffe; Julie A Auger; Danlin Xu; J Richard Thistlethwaite
Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience.
Transplantation proceedings 1998;30(4):1369-70.
1997: Dana L Johnson; Francis X Farrell; FP Barbone; FJ McMahon; Jennifer Tullai; D Kroon; J Freedy; Robert A Zivin; LS Mulcahy; Linda Jolliffe
Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity.
Chemistry & biology 1997;4(12):939-50.
1996: V L Pulito; V A Roberts; J R Adair; A L Rothermel; A M Collins; S S Varga; C Martocello; M Bodmer; Linda Jolliffe; Robert A Zivin
Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(8):2840-50.
1994: Maria-Luisa Alegre; L J Peterson; Danlin Xu; H A Sattar; D R Jeyarajah; K Kowalkowski; J Richard Thistlethwaite; Robert A Zivin; Linda Jolliffe; Jeffrey A Bluestone
A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
Transplantation 1994;57(11):1537-43.
1992: Maria-Luisa Alegre; A M Collins; V L Pulito; R A Brosius; W C Olson; Robert A Zivin; R Knowles; J Richard Thistlethwaite; Linda Jolliffe; Jeffrey A Bluestone
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(11):3461-8.
1992: E Steve Woodle; J Richard Thistlethwaite; Linda Jolliffe; Robert A Zivin; A Collins; J R Adair; M Bodmer; D Athwal; Maria-Luisa Alegre; Jeffrey A Bluestone
Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(9):2756-63.